Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  García Campayo, Javier ^a,b   Zamorano, Enric ^c   Ruiz, Miguel A ^d,e   Pardo, Antonio ^d,e   Pérez Páramo, María ^f   López Gómez, Vanessa ^f   Freire, Olga ^f   Rejas, Javier ^f  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Sant Antoni de Vilamajor Primary Care Health Center   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e EACCOS Research Group   (Spain)

^f PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONCURRENT VALIDITY; CONTENT VALIDITY; CONTROLLED STUDY; CRITERION RELATED VALIDITY; CULTURAL FACTOR; DISCRIMINANT VALIDITY; FEASIBILITY STUDY; FEMALE; GENERALIZED ANXIETY DISORDER; GENERALIZED ANXIETY DISORDER 7 SCALE; HAMILTON ANXIETY SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PSYCHOLOGIC TEST; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SOCIAL ADAPTATION; SPAIN; ANXIETY DISORDER; LANGUAGE; MASS SCREENING; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; VALIDATION STUDY;

ACCULTURATION; ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; FEMALE; HUMANS; LANGUAGE; MALE; MASS SCREENING; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; ROC CURVE; SPAIN;

EID: 77649133511     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-8     Document Type: Article

References (35)

1. Lobo A, Campos R. Los trastornos de ansiedad en atención primaria. Madrid EMISA 1997,
2. Mahe V, Valgo A. Long-term pharmacological treatment of generalized anxiety disorder. Inter Clin Psychopharmacol 2000, 15:99-105.
3. Horwath E, Weissman MM. Epidemiology of depresion and anxiety disorders. Textbook in psychiatric epidemiology 1995, Wiley-Liss, Tsuang MT, Tohen M, Zahner GEP.
4. Cano Vindel A. Trastornos de ansiedad, Sociedad Española para el estudio de la Ansiedad y el Estrés (SEAS). 2005, (last update: March 7th, 2005; last accessed: November 23rd, 2005)., http://www.ucm.es/info/seas/ta/index.htm
5. Andlin-Sobocki P, Wittchen HU. Cost of affective disorders in Europe. Eur J Neurol 2005, 12(Suppl 1):34-38. 10.1111/j.1468-1331.2005.01195.x, 15877776.
6. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL. Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatr Scan 1998, 393:6-11.
7. Stein D. Comorbidity in Generalized Anxiety Disorder: Impact and Implications. J Clin Psychiatry 2001, 62(Suppl 1):29-36.
8. The ESEMeD/MHEDEA 2000 investigators Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004, 109(Suppl 420):21-27. The ESEMeD/MHEDEA 2000 investigators.
9. A.D.A.M. MedlinePlus Información de salud para usted. Enciclopedia médica en español. Generalized anxiety disorder 2004, (Revisado por VeriMed Healthcare Network. Last update: May 4th, 2004; Last access: November 23th, 2005), A.D.A.M. MedlinePlus., http://www.nlm.nih.gov/medlineplus/spanish/ency/article/000917.htm
10. Lépine JP. The epidemiology of anxiety disorders: prevalence and societal costs. J Clin Psychiatry 2002, 63(suppl 14):4-8.
11. Wittchen HU. Generalized anxiety disorder: Prevalence, burden, and cost to society. Depression and anxiety 2002, 16:162-171. 10.1002/da.10065, 12497648.
12. Goldberg D, Lecrubier Y. Form and frequency of mental disorders across centres. Mental illness in general health care: An international study 1995, Chichester, John Wiley & Sons on behalf of WHO, Üstün TB, Sartorius N.
13. Chocrón Bentata L, Vilalta Franch J, Legazpi Rodríguez I, Auquer K, Franch L. Prevalencia de Psicopatología en un centro de atención primaria. Aten Primaria 1995, 16:586-590.
14. Hamilton M. Diagnosis and Rating of Anxiety. Br J Psychiat 1969, (special publ):76-9.
15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-70. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
16. Lipman RS, Covi L. Outpatient treatment of neurotic depression: medication and group psychotherapy. Evaluation of Psychological Therapies 1976, 178-218. Baltimore, MD: Johns Hopkins University Press, Spitzer R, Klein D.
17. Snaith RP, Baugh S, Clayden A, Husain A, Sipple NA. The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 1982, 141:518-523. 10.1192/bjp.141.5.518, 7150890.
18. Spielberger CD, Gorsuch R, Lushene RE. Manual for the State-Trait Inventory. Palo Alto: Consulting Psychological Press 1970,
19. Wittchen HU, Boyer P. Screening for anxiety disorders. Sensitivity and specificity of the Anxiety Screening Questionnaire (ASQ-15). Br J Psychiatr 1998, 173(Suppl 34):10-17.
20. Carroll BJ, Davidson JRT. Screening Scale for DSM-IV GAD. Copyright 2000,
21. Bobes J, Garcia-Calvo C, Prieto R, Garcia-Garcia M, Rico-Villademoros F. Propiedades psicométricas de la versión española de la Escala de Detección del Generalized anxiety disorder según DSM-IV de Carroll y Davidson. Actas Esp Psiquiatr 2006, 34(2):83-93.
22. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A Brief Measure for Assessing Generalized Anxiety Disorder. Arch Intern Med 2006, 166:1092-1097. 10.1001/archinte.166.10.1092, 16717171.
23. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993, 46:1417-1432. 10.1016/0895-4356(93)90142-N, 8263569.
24. Ruiz MA, Rejas J. Calidad de vida y otras medidas de salud informadas por el paciente En A. Farmacoeconomía e investigación de resultados en salud: principios y práctica 2002, 115-160. Real Academia Nacional de Farmacia, En A Domínguez, Soto J.
25. Nunnally J, Bernstein IJ. Teoría Psicométrica. México: McGraw-Hill 1995, 3.
26. Rovienelli RJ, Hambleton RK. On the use of Content Specialists in the Assessment of Criterion-Referenced Test Item Validity. Tijdschrift voor Onderwijsresearch 1977, 49-60.
27. Vázquez-Barquero JL, Vázquez Bourgón E, Herrera Castañedo S, Saiz J, Uriarte M, Morales F, Gaite L, Herrán A, Üstün TB. Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): initial phase of development and pilot study. Cantabria disability work group, Actas Esp 2000, 28:77-87. Psiquiatr.
28. World Health Organization Disability Assessment Schedule II (WHO-DAS II) 2000, WHO, Geneva, World Health Organization.
29. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psych 1951, 16:297-334.
30. Gorusch RL. Exploratory Factor Analysis: Its Role in Item Analysis. J Per Assess 1997, 68:532-560.
31. Batista-Foguet JM, Coendrs G, Alonso J. Análisis factorial confirmatorio. Su utilidad en la validación de cuestionarios relacionados con la salud. Med Clin (Barc) 2004, 122(Supl 1):21-27. 10.1157/13057542, 14980156.
32. Ruiz MA. Introducción a los modelos de ecuaciones estructurales. Madrid, UNED 2000,
33. Hair JF, Black WC, Babin BJ, Anderson RE, Tathan RL. Multivariate data analysis. Upper Saddle River 2006, NJ: Pearson-Prentice Hall.
34. Souetre E, Lozet H, Cimarosti I, Martin P, Chignon JM, Ades J, Tignol J, Darcourt G. Cost of anxiety disorders: Impact of comorbidity. J Psychosom Res 1994, 38(Suppl 1):151-160. 10.1016/0022-3999(94)90145-7, 7799247.
35. Candilis PJ, Pollack MH. The hidden costs of untreated anxiety disorders. Harv Rev Psychiatry 1997, 5:40-42. 10.3109/10673229709034724, 9385019.